Alamada, Muzaher L.

HRN: 26-74-60  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2025
CEFTRIAXONE 1G (VIAL)
02/21/2025
02/27/2025
IVT
700mg
Q24
UTI
Waiting Final Action 
02/26/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/26/2025
03/05/2025
IV
700mg
Q8
PCAP; Sepsis
Waiting Final Action 
02/26/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
02/26/2025
03/05/2025
PO
1.5ml
BID
Persistent Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: